Treatment, Tuberculosis, and Human Leukocyte Antigen
- 1 October 2002
- journal article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 166 (7) , 907-908
- https://doi.org/10.1164/rccm.2207001
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Evaluation of Clinical and Immunogenetic Risk Factors for the Development of Hepatotoxicity during Antituberculosis TreatmentAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Effects of Ethanol on Cellular Immunity to Facultative Intracellular BacteriaAlcohol, Clinical and Experimental Research, 1995
- Immunogenetics of chronic liver diseasesGastroenterology, 1994
- Association of pulmonary tuberculosis and HLA in South IndiaTubercle, 1991
- Tuberculosis in patients with various HLA phenotypesTubercle, 1990
- Association of Tuberculosis and M. tuberculosis-Specific Antibody Levels with HLAThe Journal of Infectious Diseases, 1989
- RECENT DEVELOPMENTS IN DRUG-ASSOCIATED SYSTEMIC LUPUS ERYTHEMATOSUSAdverse Drug Reaction Bulletin, 1987
- AGEING, IMMUNE RESPONSE, AND MORTALITYThe Lancet, 1974
- Isoniazid HepatitisAnnals of Internal Medicine, 1973